No takes yet. Share an insight, caveat, or question.
Research uncovers a CCL20-high immune-myeloid niche in gastric cancer, suggesting new therapeutic strategies.
Ozuner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: